The effect of different amounts of assisted reproductive drugs in endometriosis patients
Phase 2
- Conditions
- Infertility.
- Registration Number
- IRCT20200925048836N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Women with a definite diagnosis of endometriosis based on pathology report
aged between 21 and 35 years,
the first period of using ART method,
normal serum FSH concentration in primary follicular phase
, AMH>0.5, presence of both ovary
, having the ART use indication that they are willing to participate in the study.
Exclusion Criteria
history of uterine and ovary surgery
poly cystic ovarian syndrome
triggering with HCG
severe fertilizing disorder in spouse
patient with hypo gonadotrpic hypogonadism and uterine abnormality
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oocyte maturation. Timepoint: Before and after treatment. Method of measurement: Transvaginal sonography.
- Secondary Outcome Measures
Name Time Method Oocyte yield. Timepoint: Before and after treatment. Method of measurement: Transvaginal sonography and hormonal assay.